GlassScriptPhysician profile
Tyler N Cooper
NPI 1033475330
$4,521.68
in general payments reported to CMS, 2019-2025
24 companies · $465 in 2025
The $465 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $848 · 2021: $151 · 2022: $1,202 · 2023: $923 · 2024: $391 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.70 |
| Education | $116.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $888.24 | 2022 | |
| Stryker Corporation | $824.97 | 2019-2025 | Mako, 1688 |
| Arthrex, INC. | $614.61 | 2020 | |
| Zimmer Biomet Holdings, INC. | $582.74 | 2020-2025 | Maxbraid, Persona, Rosa |
| Orthalign INC | $535.34 | 2022-2023 | Orthalign Plus |
| Anika Therapeutics, INC. | $146.73 | 2024 | Tactoset, Integrity, Ovomotion |
| Depuy Synthes Sales INC. | $138.83 | 2019-2022 | |
| Baudax Bio INC. | $112.80 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $96.52 | 2024-2025 | |
| Abbott Laboratories | $75.02 | 2021-2023 | Proclaim |
| Bioventus LLC | $74.95 | 2019-2024 | Bioness Integrated System (Bits)2.0.5 |
| Horizon Therapeutics Plc | $74.36 | 2019-2022 | |
| Amgen INC. | $50.45 | 2023-2024 | Evenity, Prolia |
| Pacira Therapeutics, INC. | $49.28 | 2019 | |
| Ethicon US, LLC | $48.17 | 2024 | Ethicon, Echelon; Endopath, Vistaseal |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $45.63 | 2024-2025 | Physio-Stim |
| Heron Therapeutics, INC. | $32.10 | 2022 | |
| Globus Medical, INC. | $28.34 | 2025 | Senza |
| Zyla Life Sciences, INC. | $23.96 | 2019-2020 | |
| Medtronic, INC. | $22.39 | 2025 | Signia |
| Pfizer INC. | $18.01 | 2019 | |
| Biocomposites INC | $13.76 | 2025 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $12.57 | 2021 | |
| Merck Sharp & Dohme LLC | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.